Open AccessA Prospective, Randomized, Placebo-Controlled Study to Identify Biomarkers Associated with Active Treatment in Psoriatic Arthritis: Effects of Adalimumab Treatment on Lesional and Nonlesional Skin
Author(s) -
Marjan de Groot,
Daisy I. Picavet,
Arno W. R. van Kuijk,
Paul P. Tak,
Jan D. Bos,
Menno A. de Rie,
Marcel B. M. Teunissen
Publication year - 2012
Publication title -
dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.224
H-Index - 92
eISSN - 1421-9832
pISSN - 1018-8665
DOI - 10.1159/000343290
Subject(s) - medicine , adalimumab , psoriasis , psoriatic arthritis , placebo , gastroenterology , dermatology , pathology , tumor necrosis factor alpha , alternative medicine
There is a need for biomarkers to screen the effectiveness of (novel) therapeutic agents for psoriasis at an early stage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom